Mumbai (Maharashtra) [India], August 16: SMT (Sahajanand Medical Technologies), a global leader in innovative medical devices, proudly announces the completion of patient enrolment for the Tuxedo 2 clinical trial in India. This landmark trial aims to evaluate the efficacy and safety of Supra
The Indian Council of Medical Research (ICMR) and Panacea Biotec have announced the initiation of the first-ever Phase 3 clinical trial for a dengue vaccine in India. This landmark trial will evaluate the efficacy of India's indigenous tetravalent dengue vaccine, DengiAll, developed by Panac
Experts welcomed the Indian government's decision to waive clinical trials for drugs that have already been approved in select countries to accelerate the availability of new and innovative medicines in India, and reduce the time and cost associated with conducting clinical trials.
The centre waived local clinical trials of several drugs in India. According to the official sources, the medicines already approved by other regulatory authorities like the US, UK and EU and are not immediately available for India are not required to conduct local trials in India.
New Delhi [India], August 1: Rajiv Gandhi Cancer Institute and Research Centre (RGCIRC) has reached a landmark achievement with the successful completion of a clinical trial on telesurgery using the SSI Mantra Surgical Robotic System. This pioneering trial involved six surgical procedures in
Boston (Massachusetts) [US]/ Bangalore (Karnataka) [India], June 12: Zumutor Biologics Inc. "Zumutor", a Boston-based clinical stage Oncology Company developing first-in-class monoclonal antibody molecules targeting innate immunological pathways, today announced that the first patient was do
Kathmandu [Nepal], May 29: Trusted by 6M+ athletes worldwide, the formula offers a clinically proven 50 per cent boost in protein absorption. This is a game-changer in post-workout nutrition, promoting unparalleled recovery, and lean muscle development.
Bangalore (Karnataka) [India], May 21: A first-of-its-kind clinical trial in India shows remarkable results for people with diabetes. The trial was conducted using BugSpeaks, a flagship technology of Leucine Rich Bio, India's first microbiome-based company. BugSpeaks is a gut microbiome prof
The Subject Expert Committee (SEC) under the Central Drug Standard Control Organisation (CDSCO) has approved vaccine major Bharat Biotech International's proposal to conduct the Phase II clinical trial of Mycobacterium Tuberculosis (Live Attenuated) Vaccine to assess the safety and immunogen
New Delhi [India], April 5: CliniExperts - India's leading research-to-regulation group has recently joined hands with Manipal Academy of Higher Education (MAHE) to offer comprehensive clinical research and regulatory services to the healthcare, MedTech and Pharmaceutical industry. This part
Dublin [Ireland]/ Ahmedabad (Gujarat) [India], March 26: Veeda Clinical Research Limited, a full-service contract research organization (CRO) with a proven record of drug development success, announced that it has acquired Heads, a privately held European CRO, which specializes in conducting